ASPN Maintained by Barclays -- Price Target Raised to $5.00
Barclays has maintained an "Underweight" rating for Aspen Aerogels (ASPN) but raised its price target from $4.00 to $5.00, an increase of 25%. Despite the raised target, analysts express caution due to the stock's 29.1% overvaluation compared to its GF Value™ of $4.81 and …